
C.Uyemura & Co Ltd
TSE:4966

C.Uyemura & Co Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8 060
12 440
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does C.Uyemura & Co Ltd hold over its rivals?
What risks and challenges
does C.Uyemura & Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of C.Uyemura & Co Ltd.
Provide an overview of the primary business activities
of C.Uyemura & Co Ltd.
What unique competitive advantages
does C.Uyemura & Co Ltd hold over its rivals?
What risks and challenges
does C.Uyemura & Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for C.Uyemura & Co Ltd.
Provide P/S
for C.Uyemura & Co Ltd.
Provide P/E
for C.Uyemura & Co Ltd.
Provide P/OCF
for C.Uyemura & Co Ltd.
Provide P/FCFE
for C.Uyemura & Co Ltd.
Provide P/B
for C.Uyemura & Co Ltd.
Provide EV/S
for C.Uyemura & Co Ltd.
Provide EV/GP
for C.Uyemura & Co Ltd.
Provide EV/EBITDA
for C.Uyemura & Co Ltd.
Provide EV/EBIT
for C.Uyemura & Co Ltd.
Provide EV/OCF
for C.Uyemura & Co Ltd.
Provide EV/FCFF
for C.Uyemura & Co Ltd.
Provide EV/IC
for C.Uyemura & Co Ltd.
Show me price targets
for C.Uyemura & Co Ltd made by professional analysts.
What are the Revenue projections
for C.Uyemura & Co Ltd?
How accurate were the past Revenue estimates
for C.Uyemura & Co Ltd?
What are the Net Income projections
for C.Uyemura & Co Ltd?
How accurate were the past Net Income estimates
for C.Uyemura & Co Ltd?
What are the EPS projections
for C.Uyemura & Co Ltd?
How accurate were the past EPS estimates
for C.Uyemura & Co Ltd?
What are the EBIT projections
for C.Uyemura & Co Ltd?
How accurate were the past EBIT estimates
for C.Uyemura & Co Ltd?
Compare the revenue forecasts
for C.Uyemura & Co Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of C.Uyemura & Co Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of C.Uyemura & Co Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of C.Uyemura & Co Ltd compared to its peers.
Compare the P/E ratios
of C.Uyemura & Co Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing C.Uyemura & Co Ltd with its peers.
Analyze the financial leverage
of C.Uyemura & Co Ltd compared to its main competitors.
Show all profitability ratios
for C.Uyemura & Co Ltd.
Provide ROE
for C.Uyemura & Co Ltd.
Provide ROA
for C.Uyemura & Co Ltd.
Provide ROIC
for C.Uyemura & Co Ltd.
Provide ROCE
for C.Uyemura & Co Ltd.
Provide Gross Margin
for C.Uyemura & Co Ltd.
Provide Operating Margin
for C.Uyemura & Co Ltd.
Provide Net Margin
for C.Uyemura & Co Ltd.
Provide FCF Margin
for C.Uyemura & Co Ltd.
Show all solvency ratios
for C.Uyemura & Co Ltd.
Provide D/E Ratio
for C.Uyemura & Co Ltd.
Provide D/A Ratio
for C.Uyemura & Co Ltd.
Provide Interest Coverage Ratio
for C.Uyemura & Co Ltd.
Provide Altman Z-Score Ratio
for C.Uyemura & Co Ltd.
Provide Quick Ratio
for C.Uyemura & Co Ltd.
Provide Current Ratio
for C.Uyemura & Co Ltd.
Provide Cash Ratio
for C.Uyemura & Co Ltd.
What is the historical Revenue growth
over the last 5 years for C.Uyemura & Co Ltd?
What is the historical Net Income growth
over the last 5 years for C.Uyemura & Co Ltd?
What is the current Free Cash Flow
of C.Uyemura & Co Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for C.Uyemura & Co Ltd.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
JP |
![]() |
C.Uyemura & Co Ltd
TSE:4966
|
149.7B JPY | 1.7 | |
US |
![]() |
Sherwin-Williams Co
NYSE:SHW
|
89B USD | 3.9 |
|
US |
![]() |
Ecolab Inc
NYSE:ECL
|
71.9B USD | 4.6 |
|
JP |
![]() |
Shin-Etsu Chemical Co Ltd
TSE:4063
|
8.6T JPY | 3.4 |
|
CH |
![]() |
Givaudan SA
SIX:GIVN
|
36.7B CHF | 5 |
|
CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
25.3B EUR | 2 |
|
US |
![]() |
Dupont De Nemours Inc
NYSE:DD
|
27.7B USD | 2.2 |
|
IN |
![]() |
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR | 6.8 |
|
US |
![]() |
PPG Industries Inc
NYSE:PPG
|
25B USD | 1.6 |
|
DK |
![]() |
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 9.3 |
|
CN |
![]() |
Wanhua Chemical Group Co Ltd
SSE:600309
|
170.9B CNY | 1 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
JP |
![]() |
C.Uyemura & Co Ltd
TSE:4966
|
Average P/S:
3.8
1.7
|
6%
|
0.3 | |
US |
![]() |
Sherwin-Williams Co
NYSE:SHW
|
3.9
|
5%
|
0.8 |
|
US |
![]() |
Ecolab Inc
NYSE:ECL
|
4.6
|
4%
|
1.1 |
|
JP |
![]() |
Shin-Etsu Chemical Co Ltd
TSE:4063
|
3.4
|
N/A | N/A |
|
CH |
![]() |
Givaudan SA
SIX:GIVN
|
5
|
5%
|
1 |
|
CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
2
|
5%
|
0.4 |
|
US |
![]() |
Dupont De Nemours Inc
NYSE:DD
|
2.2
|
5%
|
0.4 |
|
IN |
![]() |
Asian Paints Ltd
NSE:ASIANPAINT
|
6.8
|
5%
|
1.4 |
|
US |
![]() |
PPG Industries Inc
NYSE:PPG
|
1.6
|
2%
|
0.8 |
|
DK |
![]() |
Novozymes A/S
CSE:NZYM B
|
9.3
|
N/A | N/A |
|
CN |
![]() |
Wanhua Chemical Group Co Ltd
SSE:600309
|
1
|
10%
|
0.1 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.